Amentum vs UL Solutions: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Amentum Holdings Inc. (AMTM)

Q3 202630 Jun – 7 Oct 2026

▲2▼2

Amentum wins big contracts but revenue misses and NASA cuts weigh

Major contract wins Amentum won NASA's COSMOS contract, joined a UK defence framework with Babcock, and secured nuclear deals including a $2.78 billion Sellafield framework and a Texas waste pilot, boosting its long-term backlog.
These new contracts are a key positive force for the stock this quarter.
Profit beat and analyst upgrade Profit beat guidance and an analyst upgrade to Neutral lifted sentiment, showing the company can manage costs even as revenue falls short.
This sentiment boost is a new positive driver for the quarter.
Revenue misses and NASA workforce cut Q2 and Q3 revenue missed expectations, and NASA's workforce directive will cut 2027 revenue by about 3%, raising concerns about near-term growth.
These are new negative developments that pressured the stock.
Weak core growth and high valuation Core growth is weak—just 1.1% annually over four years with a 2.1% free cash flow margin—and analysts expect only 1.5% growth ahead, leaving limited upside despite contract wins.
This fundamental weakness explains the stock's poor performance and cautious outlook.

August 202621 Jul – 7 Oct 2026

▲2▼1

Amentum's weak core results offset by nuclear contract wins and an upgrade

Weak revenue growth and cash flow weigh on the stock Amentum's revenue has barely grown — about 1.1% a year over four years — and its free cash flow margin averaged just 2.1%, leaving little money to reinvest. That weak core performance drove a 40.9% share price drop over six months, and analysts expect only 1.5% growth ahead.
This is the central fundamental problem behind AMTM's decline and the backdrop for everything else.
Q3 earnings: profit beat, but revenue missed Amentum reported Q3 revenue of $3.49 billion, down 2% from a year earlier and below expectations, while earnings per share of $0.67 beat the $0.63 estimate. Both business segments beat on adjusted EBITDA, but the revenue shortfall sent shares down 6% and left the company the weakest performer among government consulting peers.
The quarter is the period's key hard number: profit beat but shrinking revenue is the mixed signal driving sentiment.
Nuclear contract wins deepen long-term revenue base Amentum's joint venture OneAxIoM was named preferred supplier on a $2.78 billion Sellafield nuclear asset-care framework with a nine-year term, and Amentum joined a Texas nuclear waste disposal pilot that received a drilling permit. These long-duration nuclear deals could broaden revenue and support the company's growth story.
These are the main new positive catalysts, showing where future revenue could come from.
Analyst upgrade gives a modest sentiment lift BNP Paribas Exane upgraded Amentum to Neutral, and the stock rose 3%. It is a small positive, but an upgrade to merely Neutral shows analysts still see limited upside after the weak results and slow growth.
The upgrade is the period's only clear positive price reaction and shows sentiment stabilizing, though only slightly.

Latest21 Jul – 7 Oct 2026

▲2▼1

Amentum's weak core results offset by nuclear contract wins and an upgrade

Weak revenue growth and cash flow weigh on the stock Amentum's revenue has barely grown — about 1.1% a year over four years — and its free cash flow margin averaged just 2.1%, leaving little money to reinvest. That weak core performance drove a 40.9% share price drop over six months, and analysts expect only 1.5% growth ahead.
This is the central fundamental problem behind AMTM's decline and the backdrop for everything else.
Q3 earnings: profit beat, but revenue missed Amentum reported Q3 revenue of $3.49 billion, down 2% from a year earlier and below expectations, while earnings per share of $0.67 beat the $0.63 estimate. Both business segments beat on adjusted EBITDA, but the revenue shortfall sent shares down 6% and left the company the weakest performer among government consulting peers.
The quarter is the period's key hard number: profit beat but shrinking revenue is the mixed signal driving sentiment.
Nuclear contract wins deepen long-term revenue base Amentum's joint venture OneAxIoM was named preferred supplier on a $2.78 billion Sellafield nuclear asset-care framework with a nine-year term, and Amentum joined a Texas nuclear waste disposal pilot that received a drilling permit. These long-duration nuclear deals could broaden revenue and support the company's growth story.
These are the main new positive catalysts, showing where future revenue could come from.
Analyst upgrade gives a modest sentiment lift BNP Paribas Exane upgraded Amentum to Neutral, and the stock rose 3%. It is a small positive, but an upgrade to merely Neutral shows analysts still see limited upside after the weak results and slow growth.
The upgrade is the period's only clear positive price reaction and shows sentiment stabilizing, though only slightly.

July 202630 Jun – 19 Aug 2026

▲2▼1

Amentum's profit beat and new contract wins offset revenue miss and NASA headwind

NASA COSMOS contract win Amentum won NASA's COSMOS contract to run mission operations and astronaut training for Artemis, the Space Station and more. This adds long-term work and supports future revenue, helping lift the stock.
New contract award directly boosts AMTM's demand outlook.
Q2 revenue miss but raised profit guidance Q2 revenue fell short and the stock dropped 15%, but the company raised its full-year profit and earnings guidance, with net income jumping. The market first focused on the miss, then on the improved profitability.
This is the main earnings event that moved the stock sharply both ways.
UK defence framework with Babcock Amentum joined a five-year Babcock framework to support UK defence programmes, including nuclear and submarine work. This secures steady, long-term engineering revenue and strengthens its international defence business.
New contract expands AMTM's addressable market and revenue visibility.
NASA workforce directive cuts 2027 revenue Amentum said NASA's workforce directive will cut about 3% from fiscal 2027 revenue, though the rest of the business should grow mid-single digits. This is a real headwind that partly offsets the new contract wins.
It is a new, specific negative factor that tempers the positive outlook.

30 Jun – 19 Aug 2026

▲2▼1

Amentum's profit beat and new contract wins offset revenue miss and NASA headwind

NASA COSMOS contract win Amentum won NASA's COSMOS contract to run mission operations and astronaut training for Artemis, the Space Station and more. This adds long-term work and supports future revenue, helping lift the stock.
New contract award directly boosts AMTM's demand outlook.
Q2 revenue miss but raised profit guidance Q2 revenue fell short and the stock dropped 15%, but the company raised its full-year profit and earnings guidance, with net income jumping. The market first focused on the miss, then on the improved profitability.
This is the main earnings event that moved the stock sharply both ways.
UK defence framework with Babcock Amentum joined a five-year Babcock framework to support UK defence programmes, including nuclear and submarine work. This secures steady, long-term engineering revenue and strengthens its international defence business.
New contract expands AMTM's addressable market and revenue visibility.
NASA workforce directive cuts 2027 revenue Amentum said NASA's workforce directive will cut about 3% from fiscal 2027 revenue, though the rest of the business should grow mid-single digits. This is a real headwind that partly offsets the new contract wins.
It is a new, specific negative factor that tempers the positive outlook.

UL Solutions Inc. (ULS)

Q3 20264 Aug – 2 Oct 2026

▲4

ULS: strong Q2, AI data-center certification launch, MET Labs deal closed

Q2 results: solid underlying growth, one-time gain ULS reported Q2 revenue up 5.2% to $816 million and adjusted profit up 17.3%. Headline net income jumped 162% mostly from selling its health and safety software unit, so the real signal is steady demand plus a cash boost that lowers debt and funds growth.
The quarter's results are the core fundamental update on the business and its earnings power.
New AI data-center power certification program ULS launched a certification service for medium-voltage power units used in AI data centers, based on its UL 2877 standard. This opens a new revenue line tied to the AI buildout and strengthens its role as the safety gatekeeper for new data-center equipment.
It is a concrete new growth avenue tied to the AI infrastructure theme, not just reported results.
MET Labs acquisition completed ULS closed its €575 million purchase of Eurofins' MET Labs, adding about 1,300 staff and a global electrical and electronics testing network. This expands its applied safety science testing business and should add scale and cross-selling opportunities.
The deal closing is a major strategic step that changes ULS's size and capabilities.
UBS highlights ULS in industrial capital-spending cycle UBS named ULS among 10 industrial stocks set to benefit from a broader capital-spending upturn, citing improving manufacturing conditions. This kind of analyst endorsement can draw investor attention and support the shares, though it is an opinion, not a company result.
It reflects growing external recognition of ULS's positioning in an improving industrial cycle.

September 20264 Aug – 2 Oct 2026

▲4

ULS: strong Q2, AI data-center certification launch, MET Labs deal closed

Q2 results: solid underlying growth, one-time gain ULS reported Q2 revenue up 5.2% to $816 million and adjusted profit up 17.3%. Headline net income jumped 162% mostly from selling its health and safety software unit, so the real signal is steady demand plus a cash boost that lowers debt and funds growth.
The quarter's results are the core fundamental update on the business and its earnings power.
New AI data-center power certification program ULS launched a certification service for medium-voltage power units used in AI data centers, based on its UL 2877 standard. This opens a new revenue line tied to the AI buildout and strengthens its role as the safety gatekeeper for new data-center equipment.
It is a concrete new growth avenue tied to the AI infrastructure theme, not just reported results.
MET Labs acquisition completed ULS closed its €575 million purchase of Eurofins' MET Labs, adding about 1,300 staff and a global electrical and electronics testing network. This expands its applied safety science testing business and should add scale and cross-selling opportunities.
The deal closing is a major strategic step that changes ULS's size and capabilities.
UBS highlights ULS in industrial capital-spending cycle UBS named ULS among 10 industrial stocks set to benefit from a broader capital-spending upturn, citing improving manufacturing conditions. This kind of analyst endorsement can draw investor attention and support the shares, though it is an opinion, not a company result.
It reflects growing external recognition of ULS's positioning in an improving industrial cycle.

Latest4 Aug – 2 Oct 2026

▲4

ULS: strong Q2, AI data-center certification launch, MET Labs deal closed

Q2 results: solid underlying growth, one-time gain ULS reported Q2 revenue up 5.2% to $816 million and adjusted profit up 17.3%. Headline net income jumped 162% mostly from selling its health and safety software unit, so the real signal is steady demand plus a cash boost that lowers debt and funds growth.
The quarter's results are the core fundamental update on the business and its earnings power.
New AI data-center power certification program ULS launched a certification service for medium-voltage power units used in AI data centers, based on its UL 2877 standard. This opens a new revenue line tied to the AI buildout and strengthens its role as the safety gatekeeper for new data-center equipment.
It is a concrete new growth avenue tied to the AI infrastructure theme, not just reported results.
MET Labs acquisition completed ULS closed its €575 million purchase of Eurofins' MET Labs, adding about 1,300 staff and a global electrical and electronics testing network. This expands its applied safety science testing business and should add scale and cross-selling opportunities.
The deal closing is a major strategic step that changes ULS's size and capabilities.
UBS highlights ULS in industrial capital-spending cycle UBS named ULS among 10 industrial stocks set to benefit from a broader capital-spending upturn, citing improving manufacturing conditions. This kind of analyst endorsement can draw investor attention and support the shares, though it is an opinion, not a company result.
It reflects growing external recognition of ULS's positioning in an improving industrial cycle.